v3.26.1
Insider Trading Arrangements
3 Months Ended
Apr. 24, 2026
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Michael Marinaro [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On February 19, 2026, Michael Marinaro, Executive Vice President and President Medical Surgical Portfolio, Americas, and Global Commercial Operations, adopted a Rule 10b5-1 trading plan. Subsequently, on March 17, 2026, Mr. Marinaro amended the trading plan's starting and termination date and to provide a limit price for sales subject to the plan. The trading plan provides for the sale of up to 10,420 shares of the Company’s common stock starting as early as June 15, 2026, prior to the plan's December 15, 2026, termination date.
Name Michael Marinaro
Title Executive Vice President
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 19, 2026
Expiration Date December 15, 2026
Arrangement Duration 183 days
Aggregate Available 10,420
Matthew Walter [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On February 27, 2026, Matthew Walter, Senior Vice President, Human Resources, IT, and Global Communications & Corporate Marketing, adopted a Rule 10b5-1 trading plan. Subsequently, on April 7, 2026, Mr. Walter amended the trading plan's starting and termination date. The trading plan provides for the sale of up to 3,102 shares of the Company’s common stock starting as early as July 8, 2026, prior to the plan's July 10, 2026, termination date.
Name Matthew Walter
Title Senior Vice President, Human Resources, IT, and Global Communications & Corporate Marketing
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 27, 2026
Expiration Date July 10, 2026
Arrangement Duration 2 days
Aggregate Available 3,102